Status:
TERMINATED
Platelets Antiaggregation Control Enhancement (PACE) Study
Lead Sponsor:
Cardiochirurgia E.H.
Conditions:
Bleeding
Blood Transfusion
Eligibility:
All Genders
Phase:
NA
Brief Summary
Many patients undergo cardiac surgery without proper suspension of antiaggregation drugs. This is blamed to increase dramatically bleeding and use of allogenic blood transfusions. The investigators te...
Eligibility Criteria
Inclusion
- all patients undergoing surgical myocardial revascularization.
Exclusion
- none.
Key Trial Info
Start Date :
December 1 2010
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
September 1 2017
Estimated Enrollment :
200 Patients enrolled
Trial Details
Trial ID
NCT01218074
Start Date
December 1 2010
End Date
September 1 2017
Last Update
January 26 2018
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
European Hospital
Rome, Italy, 00149